SecBot SecBot
SECBOTREPLAY Home › Report › LGND

LGND · Director Jason Aryeh filed a Form 144 notice of intent to sell 202…

LIGAND PHARMACEUTICALS INC · 144 filed Oct 30, 2026 at 15:38 ET

At the news

NEUTRALIMPACT 1/10

144 filed Oct 30, 2026 at 15:38 ET

Director Jason Aryeh filed a Form 144 notice of intent to sell 202 shares of Ligand Pharmaceuticals common stock, with an estimated market value of approximately $64,738 based on the filing date. The proposed sale is small relative to the company's $6.4B market cap and the director's holdings, and the filing is a routine advance notice of a planned trade.

  • Director Jason Aryeh filed Form 144 on 2026-10-30 for a proposed sale of 202 shares of Ligand Pharmaceuticals common stock.
  • The estimated value of the proposed sale is $64,738.
  • The shares were acquired on 03/13/2019 via an open market purchase.
  • The proposed sale is to be executed through Charles Schwab & Co., Inc. on Nasdaq.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access